Selected research
Industry Research
Propofol Emulsion Injection Industry Research Report 2026
Market perspective
The global Propofol Emulsion Injection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Propofol Emulsion Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Propofol Emulsion Injection is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Propofol Emulsion Injection is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Propofol Emulsion Injection include Xian Libang Pharmaceutical, Teva, Sandoz, Jiangsu Nhwa Group, Pfizer, Sinopharm Guorui Pharm, Guangdong Jiabo Pharmaceutical, Fresenius Kabi and Baxter, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Propofol Emulsion Injection market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Propofol Emulsion Injection Market by Company
Xian Libang Pharmaceutical
Teva
Sandoz
Jiangsu Nhwa Group
Pfizer
Sinopharm Guorui Pharm
Guangdong Jiabo Pharmaceutical
Fresenius Kabi
Baxter
AstraZeneca
Sagent
Dr. Reddy's
B Braun
Propofol Emulsion Injection Segment by Type
20ml/vial
50ml/vial
100ml/vial
Propofol Emulsion Injection Segment by Application
Hospital
Clinics
Recovery Center
Propofol Emulsion Injection Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Propofol Emulsion Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Propofol Emulsion Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Propofol Emulsion Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Propofol Emulsion Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Propofol Emulsion Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Propofol Emulsion Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 20ml/vial
- 50ml/vial
- 100ml/vial
Applications
- Hospital
- Clinics
- Recovery Center
Companies covered
- Xian Libang Pharmaceutical
- Teva
- Sandoz
- Jiangsu Nhwa Group
- Pfizer
- Sinopharm Guorui Pharm
- Guangdong Jiabo Pharmaceutical
- Fresenius Kabi
- Baxter
- AstraZeneca
- Sagent
- Dr. Reddy's
- B Braun
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Propofol Emulsion Injection Market Size (2021-2032)
- 2.2.2 Global Propofol Emulsion Injection Sales (2021-2032)
- 2.2.3 Global Propofol Emulsion Injection Market Average Price (2021-2032)
- 2.3 Propofol Emulsion Injection by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 20ml/vial
- 2.3.3 50ml/vial
- 2.3.4 100ml/vial
- 2.4 Propofol Emulsion Injection by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinics
- 2.4.4 Recovery Center
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Propofol Emulsion Injection Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Propofol Emulsion Injection Sales (W Units) of Manufacturers (2021-2026)
- 3.3 Global Propofol Emulsion Injection Revenue of Manufacturers (2021-2026)
- 3.4 Global Propofol Emulsion Injection Average Price by Manufacturers (2021-2026)
- 3.5 Global Propofol Emulsion Injection Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Propofol Emulsion Injection, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Propofol Emulsion Injection, Product Type & Application
- 3.8 Global Manufacturers of Propofol Emulsion Injection, Established Date
- 3.9 Global Propofol Emulsion Injection Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Xian Libang Pharmaceutical
- 4.1.1 Xian Libang Pharmaceutical Company Information
- 4.1.2 Xian Libang Pharmaceutical Business Overview
- 4.1.3 Xian Libang Pharmaceutical Propofol Emulsion Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Xian Libang Pharmaceutical Propofol Emulsion Injection Product Portfolio
- 4.1.5 Xian Libang Pharmaceutical Recent Developments
- 4.2 Teva
- 4.2.1 Teva Company Information
- 4.2.2 Teva Business Overview
- 4.2.3 Teva Propofol Emulsion Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Teva Propofol Emulsion Injection Product Portfolio
- 4.2.5 Teva Recent Developments
- 4.3 Sandoz
- 4.3.1 Sandoz Company Information
- 4.3.2 Sandoz Business Overview
- 4.3.3 Sandoz Propofol Emulsion Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Sandoz Propofol Emulsion Injection Product Portfolio
- 4.3.5 Sandoz Recent Developments
- 4.4 Jiangsu Nhwa Group
- 4.4.1 Jiangsu Nhwa Group Company Information
- 4.4.2 Jiangsu Nhwa Group Business Overview
- 4.4.3 Jiangsu Nhwa Group Propofol Emulsion Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Jiangsu Nhwa Group Propofol Emulsion Injection Product Portfolio
- 4.4.5 Jiangsu Nhwa Group Recent Developments
- 4.5 Pfizer
- 4.5.1 Pfizer Company Information
- 4.5.2 Pfizer Business Overview
- 4.5.3 Pfizer Propofol Emulsion Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Pfizer Propofol Emulsion Injection Product Portfolio
- 4.5.5 Pfizer Recent Developments
- 4.6 Sinopharm Guorui Pharm
- 4.6.1 Sinopharm Guorui Pharm Company Information
- 4.6.2 Sinopharm Guorui Pharm Business Overview
- 4.6.3 Sinopharm Guorui Pharm Propofol Emulsion Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Sinopharm Guorui Pharm Propofol Emulsion Injection Product Portfolio
- 4.6.5 Sinopharm Guorui Pharm Recent Developments
- 4.7 Guangdong Jiabo Pharmaceutical
- 4.7.1 Guangdong Jiabo Pharmaceutical Company Information
- 4.7.2 Guangdong Jiabo Pharmaceutical Business Overview
- 4.7.3 Guangdong Jiabo Pharmaceutical Propofol Emulsion Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Guangdong Jiabo Pharmaceutical Propofol Emulsion Injection Product Portfolio
- 4.7.5 Guangdong Jiabo Pharmaceutical Recent Developments
- 4.8 Fresenius Kabi
- 4.8.1 Fresenius Kabi Company Information
- 4.8.2 Fresenius Kabi Business Overview
- 4.8.3 Fresenius Kabi Propofol Emulsion Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Fresenius Kabi Propofol Emulsion Injection Product Portfolio
- 4.8.5 Fresenius Kabi Recent Developments
- 4.9 Baxter
- 4.9.1 Baxter Company Information
- 4.9.2 Baxter Business Overview
- 4.9.3 Baxter Propofol Emulsion Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Baxter Propofol Emulsion Injection Product Portfolio
- 4.9.5 Baxter Recent Developments
- 4.10 AstraZeneca
- 4.10.1 AstraZeneca Company Information
- 4.10.2 AstraZeneca Business Overview
- 4.10.3 AstraZeneca Propofol Emulsion Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 AstraZeneca Propofol Emulsion Injection Product Portfolio
- 4.10.5 AstraZeneca Recent Developments
- 4.11 Sagent
- 4.11.1 Sagent Company Information
- 4.11.2 Sagent Business Overview
- 4.11.3 Sagent Propofol Emulsion Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Sagent Propofol Emulsion Injection Product Portfolio
- 4.11.5 Sagent Recent Developments
- 4.12 Dr. Reddy's
- 4.12.1 Dr. Reddy's Company Information
- 4.12.2 Dr. Reddy's Business Overview
- 4.12.3 Dr. Reddy's Propofol Emulsion Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Dr. Reddy's Propofol Emulsion Injection Product Portfolio
- 4.12.5 Dr. Reddy's Recent Developments
- 4.13 B Braun
- 4.13.1 B Braun Company Information
- 4.13.2 B Braun Business Overview
- 4.13.3 B Braun Propofol Emulsion Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 B Braun Propofol Emulsion Injection Product Portfolio
- 4.13.5 B Braun Recent Developments
5 Global Propofol Emulsion Injection Market Scenario by Region
- 5.1 Global Propofol Emulsion Injection Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Propofol Emulsion Injection Sales by Region: 2021-2032
- 5.2.1 Global Propofol Emulsion Injection Sales by Region: 2021-2026
- 5.2.2 Global Propofol Emulsion Injection Sales by Region: 2027-2032
- 5.3 Global Propofol Emulsion Injection Revenue by Region: 2021-2032
- 5.3.1 Global Propofol Emulsion Injection Revenue by Region: 2021-2026
- 5.3.2 Global Propofol Emulsion Injection Revenue by Region: 2027-2032
- 5.4 North America Propofol Emulsion Injection Market Facts & Figures by Country
- 5.4.1 North America Propofol Emulsion Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Propofol Emulsion Injection Sales by Country (2021-2032)
- 5.4.3 North America Propofol Emulsion Injection Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Propofol Emulsion Injection Market Facts & Figures by Country
- 5.5.1 Europe Propofol Emulsion Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Propofol Emulsion Injection Sales by Country (2021-2032)
- 5.5.3 Europe Propofol Emulsion Injection Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Propofol Emulsion Injection Market Facts & Figures by Country
- 5.6.1 Asia Pacific Propofol Emulsion Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Propofol Emulsion Injection Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Propofol Emulsion Injection Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Propofol Emulsion Injection Market Facts & Figures by Country
- 5.7.1 South America Propofol Emulsion Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Propofol Emulsion Injection Sales by Country (2021-2032)
- 5.7.3 South America Propofol Emulsion Injection Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Propofol Emulsion Injection Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Propofol Emulsion Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Propofol Emulsion Injection Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Propofol Emulsion Injection Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Propofol Emulsion Injection Sales by Type (2021-2032)
- 6.1.1 Global Propofol Emulsion Injection Sales by Type (2021-2032) & (W Units)
- 6.1.2 Global Propofol Emulsion Injection Sales Market Share by Type (2021-2032)
- 6.2 Global Propofol Emulsion Injection Revenue by Type (2021-2032)
- 6.2.1 Global Propofol Emulsion Injection Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Propofol Emulsion Injection Revenue Market Share by Type (2021-2032)
- 6.3 Global Propofol Emulsion Injection Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Propofol Emulsion Injection Sales by Application (2021-2032)
- 7.1.1 Global Propofol Emulsion Injection Sales by Application (2021-2032) & (W Units)
- 7.1.2 Global Propofol Emulsion Injection Sales Market Share by Application (2021-2032)
- 7.2 Global Propofol Emulsion Injection Revenue by Application (2021-2032)
- 7.2.1 Global Propofol Emulsion Injection Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Propofol Emulsion Injection Revenue Market Share by Application (2021-2032)
- 7.3 Global Propofol Emulsion Injection Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Propofol Emulsion Injection Value Chain Analysis
- 8.1.1 Propofol Emulsion Injection Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Propofol Emulsion Injection Production Mode & Process
- 8.2 Propofol Emulsion Injection Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Propofol Emulsion Injection Distributors
- 8.2.3 Propofol Emulsion Injection Customers
9 Global Propofol Emulsion Injection Analyzing Market Dynamics
- 9.1 Propofol Emulsion Injection Industry Trends
- 9.2 Propofol Emulsion Injection Industry Drivers
- 9.3 Propofol Emulsion Injection Industry Opportunities and Challenges
- 9.4 Propofol Emulsion Injection Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst